Background Image
Table of Contents Table of Contents
Previous Page  25 / 56 Next Page
Information
Show Menu
Previous Page 25 / 56 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Vol 26, No 5, October/November 2015

AFRICA

23

There is a need to document GAS carriage in school children

of all ages, which, together with the molecular characterisation

(M-typing) of strains harboured in the pharynx of carriers,

will help to ascertain the extent to which disease strains are

prevalent among carriers. This background information would

serve to assist healthcare providers in diagnosing symptomatic

GAS pharyngitis, as well as potentially contributing to the

development of a GAS vaccine. Currently, data on prevalence

of GAS carriage and M-type distribution in African countries

are largely scant. We therefore undertook to perform a system-

atic review to determine the prevalence and type distribution of

asymptomatic streptococcus carriage in children aged five to 15

years, residing in African countries.

Methods:

We conducted a comprehensive literature search

among a number of databases, using an African search filter to

identify GAS prevalence studies that report on children between

the ages of five and 15 years who reside in African countries.

Electronic searches were complemented by a hand-search

performed on reference lists of potentially included studies. The

search was not limited by year of publication and language.

Two evaluators independently reviewed, rated and abstracted

data from each article. Prevalence estimates were pooled in

a meta-analysis and stratified according to region and study

design, using Stata

®

. Specifically, we applied the random-effects

metaprop routine to aggregate prevalence estimates and account

for between-study variability in calculating the overall pooled

estimates and 95% CI for prevalence of GAS carriage.

Results:

Of the 1 665 articles retrieved, 16 studies incorporat-

ing cross-sectional and longitudinal study designs met with the

inclusion criteria. The pooled prevalence of GAS carriage was

8% [95% confidence interval (CI), 5–10%] with pooled preva-

lences for cross-sectional studies equal to 8% (95% CI, 5–11%)

and longitudinal studies, 9% (95% CI, 1–24%). Regional pooled

rates were similar across East, Central and Southern Africa of

between 7 and 8%, while countries within northern Africa had

a pooled estimate of 14% (95% CI, 3–30%). Western Africa had

the lowest pooled estimate of 2% (95% CI, 1–2%). Only one

study reported data on molecular characterisation, of which

11/13 (85%) emm-types were included among the putative

30-valent vaccine currently under development.

Conclusion:

This study revealed a pooled GAS carriage estimate

of 8% among African school children. Regional differences in

carriages were largely minimal except for West and North Africa

with prevalences of 2 and 14%, respectively. There is a dearth of

data on molecular strain information, therefore emphasising the

need for further studies.

CENTRALARTERIALSTIFFNESS INZAMBIANNORMO-

TENSIVE AND HYPERTENSIVE PARTICIPANTS

Mushabati Festus*

1

, Goma Fastone M

2

, Lwiindi Lukubi

3

,

Siulapwa Nathan J

1

, Siziya Sete

1

*

Copperbelt University, School of Medicine, Ndola, Zambia;

facemushabati@yahoo.com

2

University of Zambia, Zambia

3

Lusaka Apex Medical University, Zambia

Background:

Central arterial stiffness is a strong and independ-

ent predictor of cardiovascular events and mortality, including

hypertension, in any given population. A few studies have found

that being black could be associated with elevated arterial stiff-

ness, thereby accounting for the high prevalence of hypertension

in these populations. The present study sought to determine

and compare central arterial stiffness using carotid femoral

PWV (cfPWV) in a population of Zambian normotensive (NT)

and hypertensive (HT) participants [both treated (HTC) and

untreated hypertensives (HTN)] between 30 and 65 years of age.

Methods:

cfPWVwas measured in 146 participants. AComplior

®

analysis device (Version 1.9 Beta 2013; ALAMMedical, France)

was used. Superficial pulses were accessed non-invasively over

the carotid–femoral segment.

Results:

The cfPWV values in the HTN participants (

n

=

23)

were significantly higher than in the NT (

n

=

64) participants

(11.4

±

4.2 m/s vs 9.1

±

3.2 m/s,

p

=

0.009). In the HTC partici-

pants (

n

=

59), their cfPWV values (10.4

±

5.6 m/s) tended to

approach those in the HTN participants, but with no statistical

differences between them (

p

>

0.500). Furthermore, the mean

cfPWV found in the NT participants was considerably higher

than any found in previous studies, especially in white-skinned

populations. Carotid femoral PWV did not show significant

age-related increase in all three blood pressure categories (

r

2

<

0.03,

p

>

0.100).

Conclusion:

These findings show that central elastic arteries of

HT participants, regardless of being on anti-hypertensive ther-

apy or not, were stiffer and therefore less compliant than those

in the NT participants, adding to their burden of hypertension.

Regrettably, the HTC participants showed poor BP control,

inferred from their considerably high cfPWV values that tended

to approach the stiffness values of the untreated group.

BENZATHINE PENICILLINADHERENCE FOR SECOND-

ARY PROPHYLAXIS AMONG PATIENTS AFFECTED

WITH RHEUMATIC HEART DISEASE ATTENDING THE

MULAGO HOSPITAL

Musoke Charles*

1

, Mondo Charles Kiiza

1

, Okello Emmy

2

,

Zhang Wanzhu

2

, Kakande Barbara

2

, Nyakoojo Wilson

2

, Freers

Juergen

3

1

Mulago National Referral Hospital; and Uganda Heart

Institute, Kampala, Uganda;

jxyug@yahoo.com

2

Uganda Heart Institute, Kampala, Uganda

3

Makerere University, Kampala, Uganda

Introduction:

Rheumatic heart disease (RHD) frequently occurs

following recurrent episodes of acute rheumatic fever (ARF).

Benzathine penicillin (benzapen) is the most effective method

for secondary prophylaxis against ARF, whose efficacy largely

depends on adherence to treatment. Various factors determine

adherence to therapy but there are no data regarding current

use of benzapen in patients with RHD attending the Mulago

Hospital. The study aims were (1) to determine the levels of

adherence with benzapen prophylaxis among RHD patients

at the Mulago Hospital, and (2) establish the patient factors